Results 381 to 390 of about 3,106,146 (396)

Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma

Journal of Oncology Pharmacy Practice, 2013
J. Steele
semanticscholar   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Nature Medicine, 2018
Yuting Sun, Jeffrey J Ackroyd, Stefan O Ciurea   +2 more
exaly  

Proteasome Inhibitors: Introduction

Seminars in Hematology, 2012
Christoph J. Heuck, John D. Shaughnessy
openaire   +1 more source

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

Nature Reviews Cancer, 2008
Ludger Hengst, Joyce M Slingerland
exaly  

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Nature, 2009
Michael A Milhollen, James J Garnsey, Lawrence R Dick   +2 more
exaly  

Proteasome and Protease Inhibitors

2019
Franke, N.E., Vink, J., Cloos, J., Kaspers, G.J.L.   +3 more
openaire   +3 more sources

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

Nature Medicine, 2003
Laurent Meijer
exaly  

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Nature Medicine, 2018
Jacqulyne Robichaux, Yasir Y Elamin, Zhi Tan   +2 more
exaly  

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Cancer Cell, 2011
Wei Xu, Hui Yang, Ping Wang
exaly